Residual Lung Disease at Six-month Follow-up CT after COVID-19: Clinical Significance Is a Key Issue.

Wells, Athol U; Devaraj, Anand

Wells, Athol U; Devaraj, Anand.

Wells AU; From the Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London SW3 6NP, England (A.U.W.); The National Heart and Lung Institute, Imperial College London, London, England (A.U.W., A.D.); and Department of Radiology, Royal Brompton Hospital, London, England (A.D.).
Devaraj A; From the Interstitial Lung Disease Unit, Royal Brompton and Harefield NHS Foundation Trust, Sydney Street, London SW3 6NP, England (A.U.W.); The National Heart and Lung Institute, Imperial College London, London, England (A.U.W., A.D.); and Department of Radiology, Royal Brompton Hospital, London, England (A.D.).

Radiology ; 301(2): E406-E408, 2021 11.

Article in English | MEDLINE | ID: covidwho-1484081

Subject(s)

COVID-19; Follow-Up Studies; Humans; Lung/diagnostic imaging; SARS-CoV-2; Tomography, X-Ray Computed

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Cohort study / Prognostic study Limits: Humans Language: English Journal: Radiology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google